Update 1: AstraZeneca Announces Research Deal
115138
Pharmaceutical giant AstraZeneca PLC said Monday it bought a 20 percent stake in biology company Cambridge Antibody Technology as the two companies announced a US$175 million five-year research and development alliance on inflammatory disorders, including
361656
IBM Corp. said Monday it has won a $1.4 billion outsourcing contract from AstraZeneca PLC, a seven-year deal aimed at helping the British pharmaceutical company manage its internal technology operations.
460971
Will AstraZeneca become the latest casualty in the drug safety debate?
725269
GlaxoSmithKline Plc (GSK.L: Quote, Profile, Research) has agreed to disclose information on all clinical studies of its drugs to settle a lawsuit that accused it of withholding negative information about the antidepressant Paxil, the
351992
In the latest endorsement of a science technique discovered at the University of Massachusetts, the international drug giant Roche signed a $331 million deal with Alnylam Pharmaceuticals Inc. of Cambridge for the rights to develop drugs using RNA interference.
426040
AstraZeneca Plc has won U.S. approval to  market its Nexium ulcer pill as a treatment that reduces the  risk of ulcers developing in patients on non-steroidal  anti-inflammatory drugs, it said on Monday.
431734
Drug manufacturer AstraZeneca PLC announced Friday that trials of its new lung cancer drug found it didn't help patients live longer. Its shares dropped more than 8 percent.
108565
Danish biotech Genmab A/S on Tuesday signed a deal worth up to $2.1 billion with pharmaceutical company GlaxoSmithKline PLC for the global commercialization of a leukemia treatment.
115547
AstraZeneca Plc's experimental cancer  drug AZD2281 has been given orphan drug status by the European  Medicines Agency for treating women with ovarian cancer,  Britain's second biggest drugmaker said on Tuesday.
457209
Akzo Nobel  said on Monday it was selling its drugs unit Organon BioSciences to Schering-Plough  for 11 billion euros ($14.4 billion), in a last-minute reversal of plans to float it on the stock market.
106113
Shares in AstraZeneca tumbled today after a key drug it has developed in the fight against strokes was provisionally rejected by US regulators.
583185
Consolidation in Europe's drugs  sector gathered steam on Thursday as Germany's Merck unveiled a  $13.3-billion deal to buy Europe's top biotech firm Serono, and  Denmark's Nycomed won the drugs unit of Altana.
752652
AstraZeneca is spending 75 million pounds to take a 20 percent stake in Cambridge Antibody Technology and boost its position in one of the fastest-growing fields of drug research.
853
AstraZeneca, the troubled Anglo-Swedish drugs giant, is being urged by shareholders to waive a one million-pound (1.4 million-euro, 1.9 million-dollar) bonus being lined up for chief executive Tom McKillop following a string of company setbacks, a newspaper reported.
47283
British pharmaceutical giant GlaxoSmithKline and Anglo-Swedish peer AstraZeneca are being investigated over bribes allegedly paid to Saddam Hussein's deposed Iraqi regime, they confirmed Saturday.
557027
Drug maker GlaxoSmithKline, which has co-US headquarters in Philadelphia and Research Triangle Park, has acquired exclusive rights to a potential diabetes treatment in a deal that could be worth more than $180 million.
764957
SHARES in drugs giant AstraZeneca bounced back having slumped to a 19-month low earlier today as US regulators formally blocked the launch of its new blood-thinning treatment Exanta.